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Poverty is correlated with negative health outcomes in pediatric primary care and subspecialties; its asso-
ciation with childhood hematopoietic stem cell transplantation (HSCT) patterns of care and clinical outcomes
is not known. We describe family-reported ﬁnancial hardship at a primary referral center in New England and
explore the relationship between measures of poverty and patterns of care and clinical outcomes. Forty-ﬁve
English-speaking parents of children after allogeneic HSCT in the prior 12 months completed a 1-time survey
(response rate 88%). Low-income families, deﬁned as 200% federal poverty level (FPL), were compared with
all others. Eighteen (40%) families reported pre-HSCT incomes 200% FPL. Material hardship, including food,
housing, or energy insecurity was reported by 17 (38%) families in the cohort. Low-income families reported
disproportionate transplantation-related income losses, with 7 (39%) reporting annual income losses of >40%
compared with 2 (18%) wealthier families (P ¼ .02). In univariate analyses, 11 (61%) low-income children
experienced graft-versus-host disease (GVHD) of any grade in the ﬁrst 180 days after HSCT compared with 2
(7%) wealthier children (P ¼ .004). We conclude that low income and, in particular, material hardship, are
prevalent in a New England pediatric HSCT population and represent targets for improvement in quality of
life. The role of poverty in mediating GVHD deserves further investigation in larger studies that can control for
known risk factors and may provide a targetable source of transplantation-associated morbidity.
 2015 American Society for Blood and Marrow Transplantation.INTRODUCTION
Pediatric allogeneic hematopoietic stem cell trans-
plantation (HSCT) can provide life-saving treatment for
children with malignant and nonmalignant diseases. Steady
advances in HSCT donor selection, stem cell source, condi-
tioning regimens, and supportive care have led to improved
medical outcomes, and the frequency of HSCT in pediatrics is
increasing annually [1]. Despite these advancements, pedi-
atric HSCT remains a physically and emotionally demanding
treatment for children and their families. Transplantation-
related morbidity and mortality remain substantial [1], and
research into the psychosocial impact of pediatric HSCT has
demonstrated high levels of family distress despite standard
institutional supportive care interventions [2,3].edgments on page 317.
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ty for Blood and Marrow Transplantation.Financial hardship is increasingly being recognized as a
consequence of adult and childhood cancer treatment [4-12].
Poverty is known to be correlated with negative health
outcomes, including mortality, in pediatric primary care and
chronic illness [13-25]. Studies in families of children with
cancer report that ﬁnancial distress is associated with
frequent admissions, consequent work disruptions, and
limited access to ﬁnancial support [12,26]. High-risk pedi-
atric cancer families include those whose children experi-
ence long admissions, those treated far from home, and
poorer families [5,9,27]. Data about parental employment in
pediatric cancer suggest that as many as three quarters of
parents suffer work disruption because of therapy [5,8,9].
Resultant catastrophic ﬁnancial hardship, including income
losses of >40% due to treatment, has been described in up to
20% of families of children with advanced cancer and
bereaved families [8,9]. Moreover, families with low income
before therapy disproportionately suffer such impact [8,9].
Despite this emerging evidence of substantial ﬁnancial
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about the economic hardship experienced by families of
children undergoing pediatric HSCT.
It stands to reason that the more intensive treatment
characteristics of HSCTdincluding prolonged inpatient ad-
missions, therapy far from home at referral centers, and the
need for full-time parental caretaking secondary to isolation
precautionsdmay impose an even greater burden on families
than chemotherapy alone. Indeed, recent studies in adult re-
cipients of allogeneic HSCT have demonstrated substantial
ﬁnancial burden [28,29]. For example, in a retrospective sur-
vey of adult HSCT survivors, Khera et al. found that more than
two thirds reported their sickness had hurt them ﬁnancially,
and nearly one half reported transplantation-related house-
hold income losses of >50% [28].
Though disease relapse represents the leading cause of
post-transplantation death in pediatric HSCT, transplantation-
related complications including graft-versus-host disease
(GVHD) and infection continue to account for signiﬁcant
morbidity and mortality [1]. Identiﬁcation of children at
increased risk for these complications based on donor and
recipient biologic characteristics has allowed for more indi-
vidualized preventive measures [30]. Although little is known
about the role of socioeconomic status in mediating HSCT
complications in children, recent studies in adults have pro-
vided provocative evidence that socioeconomic status may
affect these outcomes [31,32]. To our knowledge, no studies
have explored the prevalence of poverty and ﬁnancial burden
in pediatric HSCT, nor have any examined the relationship
betweenmeasures of poverty and HSCT outcomes in children.
We aimed to describe the prevalence of family-reported
income poverty and concrete resource needsd2 important
measures of ﬁnancial hardshipdin families of children un-
dergoing allogeneic HSCT at a major pediatric referral center
in New England. We further sought to describe the impact of
HSCT on parental employment and income and to explore the
relationship between baseline family income poverty and
child patterns of care and clinical outcomes.
MATERIALS AND METHODS
The Stem Cell Transplant Economic Impact Study (SCT EIS) was con-
ducted at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
(DF/BCH) in Boston, Massachusetts. DF/BCH is the primary regional referral
center in New England for pediatric stem cell transplantations serving
children from Massachusetts, Maine, New Hampshire, Vermont, Rhode Is-
land, and Connecticut as well as national and international referrals. This
study was approved by the Dana-Farber Cancer Institute’s institutional re-
view board.
Study Population
The SCT EIS was administered in a cross-sectional cohort of pediatric
transplantation families whose child had undergone allogeneic stem cell
transplantation for any underlying disease at DF/BCH between December
2010 and September 2012. Parents/legal guardians were eligible to partici-
pate if the child’s transplantation occurred a minimum of 30 days and a
maximum of 12 months before survey completion, the parent/legal guard-
ian spoke English, and the primary treating physician provided permission
to approach. Parents of children who had died during or after trans-
plantation and before our ability to approach for consent were excluded
from participation. Foreign national families residing in Boston exclusively
for the child’s transplantation with intent to return to their native country
shortly after transplantation were also excluded from participation.
Clinical Care Team Context
All children enrolled in this study received psychosocial support ser-
vices per institutional standard. Consequently, 100% of families enrolled in
this study had a dedicated psychosocial clinician who followed them from
the time of transplantation through the post-transplantation time period to
address the emotional consequences of illness. In addition, 100% of families
met with a member of the pediatric hematology/oncology resourcespecialist team, which focuses exclusively on identifying and ameliorating
concrete resource needs for families undergoing pediatric cancer treatment
or stem cell transplantation, at the time of transplantation.
Data Collection
Survey administration
We identiﬁed 65 eligible families and the primary provider permitted
approach in 63 of these. Fifty-one of the 63 eligible families were
approached in person by the study’s principal investigator (PI) or a trained
research assistant in the outpatient clinic or inpatient ﬂoor; 12 families
attended clinic visits on days neither the PI nor research assistant were
available to consent and, thus, were not approached. Participants completed
a 1-time, face-to-face survey at the time of enrollment. Survey questions
were read aloud to participating parents; thus, the ability to read or write
was not necessary. Joint parental participation in answering questions about
family ﬁnances was allowed. One parent was asked to identify himself or
herself as the primary study participant to answer demographic and psy-
chosocial questions. Employment and income questions were asked about
all adults ﬁnancially supporting the child. Surveys were administered be-
tween August 2011 and April 2013, a median of 132 (interquartile range
[IQR], 96) days after transplantation, and administration took an average of
39 minutes.
Instrument development
The 120-item SCT EIS survey was developed with the aim of exploring 4
domains of family economics: (1) baseline prevalence of income poverty, (2)
impact of the child’s transplantation on parental employment, family in-
come, and reported ﬁnancial security, (3) prevalence of material hardship
during the post-transplantation period, and (4) the relationship between
family income and child’s outcomes. Where possible, the survey incorpo-
rated questions from previously published instruments [33-37]. Additional
survey items were derived de novo based on a comprehensive review of the
general pediatric and subspecialty pediatrics literature; interviews with
HSCT and pediatric oncology families; and consensus opinions from pedi-
atric stem cell transplantation physicians, pediatric oncologists, palliative
care physicians, and resource specialists. All items were closed-ended
questions or multiple choice. The survey was piloted in face-to-face in-
terviews with pediatric oncology and HSCT families to reﬁne the domains of
inquiry and assess item wording, respondent burden and willingness to
participate. The survey instrument is available in the Appendix S1.
Chart abstraction
Medical chart abstraction was performed by a trained research assistant
and duplicated by the PI for each patient from the date of stem cell infusion
through 6 months after transplantation. Discrepancies between the 2 ab-
stracters were discussed, and ﬁnal coding was determined by consensus.
Data elements included date of birth, gender, HSCTmedical indication, HSCT
source, HSCT conditioning regimen, duration of hospitalization for HSCT,
number of unplanned admissions after HSCT, any intensive care unit stay,
and occurrence of any GVHD.
Operational Deﬁnition of Variables
Material hardship
Material hardship was assessed in 3 domains: food insecurity, housing
insecurity, and energy insecurity. Housing insecurity and energy insecurity
are constructs for which no ofﬁcial United States measures exist. We chose
to assess these concrete resource needs in accordance with previously
published general pediatrics measures known to have statistically signiﬁ-
cant associations with child health outcomes [15,16].
Food insecurity. Measured and deﬁned utilizing the validated US Household
Food Security SurveyModule: Six-Item Short Form and scored in accordance
with established guidelines [34,38]. This measure utilizes a standardized 12-
month reference period, which, therefore, was not speciﬁc to but included
the post-transplantation period.
Housing insecurity. Families were considered to be “housing insecure” if
they reported any of the following: (1) crowding, deﬁned as >2 people per
bedroom in the home at the time of survey administration after trans-
plantation, (2) multiple moves, deﬁned as >1 move in the prior year in
response to the question, “Howmany places have you and your child lived in
the past year,” or (3) doubling up after transplantation, deﬁned as an afﬁr-
mative answer to the question, “Since your child’s transplantation, have you
and your child had to temporarily live with other people, even for a little
while, because of ﬁnancial difﬁculties?”
Energy security. Families were considered to be “energy insecure” if they
answered afﬁrmatively to any of the following questions: (1) “Since your
Table 1
Child, Disease, and Family Characteristics*
Total
N ¼ 45
Baseline Annual Family Income as Percent of FPLy P
200%
n ¼ 18 (40)
>200%
n ¼ 27 (60)
Child, disease, and care characteristics
Female 20 (44) 6 (33) 14 (52) .40
Age, median (IQR) 10 (4-16) 12 (8-16) 7 (3-16) .20
Diagnosis
Malignancy 30 (67) 13 (72) 17 (63) .40
Bone marrow failure 9 (20) 3 (17) 6 (22)
Benign hematology 3 (7) 2 (11) 1 (4)
Immunodeﬁciency 3 (7) 0 (0) 3 (11)
Stem cell source
Matched sibling marrow donor 19 (42) 5 (28) 14 (52) .10z
Unrelated donor
Matched unrelated marrow 19 (42) 10 (55) 9 (33)
Cord 7 (16) 3 (17) 4 (15)
Health insurance
Private only 19 (42) 3 (17) 16 (59) .01
Private plus Medicaid 15 (33) 7 (39) 8 (30)
Medicaid only 11 (24) 8 (44) 3 (11)
Parental demographics
Parent completing survey: Mother 37 (82) 15 (83) 22 (81) 1.00
Age, median (IQR), yr 40 (35-46) 40 (35-45) 40 (35-46) .60
Education
High school education or less 19 (42) 10 (56) 9 (33) .03
Associate/Bachelors 18 (40) 8 (44) 10 (37)
Masters/Doctorate 8 (18) 0 (0) 8 (30)
Ethnicity: Hispanic or Latino 6 (13) 4 (22) 2 (7) .20
Race: non-white 4 (9) 2 (11) 2 (7) .10
Household characteristics
English spoken as primary language at home 42 (93) 15 (83) 27 (100) .06
Single parent household 7 (16) 6 (33) 1 (4) .01
Household size, median (IQR) 4 (4-5) 4 (4-6) 5 (4-5) .80
Household income before transplantation,
median (IQR)
$64,920
($40,000-$100,000)
$35,500
($15,000-$546,80)
$94,000
($76,440-$146,848)
NA
More than 1 adult ﬁnancially contributes
to child’s care
27 (60) 11 (61) 16 (60) 1.00
NA indicates not available.
Data presented are n (%), unless otherwise indicated. P values: Fisher’s exact test was applied for categorical variables and Wilcoxon rank sum test was applied
for continuous variables.
* Survey questions available in Appendix S1.
y Baseline family income was divided by the year-speciﬁc poverty guideline for household size and multiplied by 100 to achieve percentage of FPL.
z P value is for a Fisher’s exact test of matched sibling marrow versus (matched unrelated marrow or cord)
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threatening to shut off the gas/electricity/oil to the house for not paying
bills,” (2)”Since your child’s transplant, has the gas/electric/oil company shut
off electricity or refused to deliver oil/gas for not paying bills,” (3) “Since
your child’s transplant, were there any days that your homewas not heated/
cooled because you couldn’t pay the bills,” or (4) “Since your child’s trans-
plant, have you ever used a cooking stove to heat your home because you
couldn’t pay the bills?”
Families were deﬁned as havingmaterial hardship if they experienced at
least 1 of the above 3 concrete needs.
Family economic variables
Baseline family income as a percent of federal poverty level (FPL). Baseline
family income was calculated by adding reported gross annual income for all
adults ﬁnancially contributing to the child’s care. Baseline family income was
then transformed into a percentage of FPL for the year the survey was
administered and stratiﬁed into 2 levels (200% and >200%). Year-speciﬁc
FPLs were based on the Department of Health and Human Services Poverty
Guidelines and calculated as follows: baseline family income was divided by
the year-speciﬁc poverty guideline for household size and multiplied by 100
to achieve percentage of FPL [39]. Stratiﬁcation at 200% FPL is in concert
with published deﬁnitions of low-income families and additionally identiﬁes
a cohort of families who may be eligible for governmental support.
Percent annual income lost due to child’s transplantation was calculated
by dividing reported income loss due to transplantation by baseline family
income. This was stratiﬁed as follows: 10%, 11% to 40%, and >40%. These
cut-off points were determined before data analysis in accord with previous
publications [8] and correspond to levels of income consumed by health
expenditures that are likely to push households into poverty; namely,
catastrophic expenditures [40,41].Family ﬁnancial hardship. This 4-item ordinal scale, previously published in
the pediatric oncology and palliative care literature, was collapsed into 3
categories: great, moderate, and no or a little economic hardship [8].
Statistical Methods
Child, disease, and family characteristics were described with fre-
quencies, means and medians as appropriate to sample size. To test whether
baseline characteristics or the ﬁnancial impact of transplantation varied
across FPL, Fisher’s exact test was applied for categorical variables and a
Wilcoxon rank-sum test was applied for continuous variables. To explore the
association between FPL and clinical outcomes, a Cochran-Mantel-Haenszel
test was applied for categorical variables and a Wilcoxon rank-sum test was
applied for continuous variables. Analyses were conducted using SAS v.9.3
for windows statistical package (SAS Institute Inc., Cary, NC).
RESULTS
Of the 51 eligible families approached, 45 agreed to
participate (response rate 88%). Of these, all families had
100% completed data for analysis.
Child and Disease Characteristics
Demographic and disease characteristics of the 45 fam-
ilies are presented in Table 1. Median age at time of trans-
plantationwas 10 years, and just under one half of the cohort
(44%) was female. The most common indication for trans-
plantation was malignancy (67%). Marrow was the principle
Table 2
Family Financial Impact of Child’s Stem Cell Transplantation*
Total
N ¼ 45
Baseline Annual Family Income
as Percent of FPLy
P
200%
n ¼ 18 (40)
>200%
n ¼ 27 (60)
Income
Percent family income lost due to work disruptions
10% 16 (36) 6 (33) 10 (37) .02
11%-40% 20 (44) 5 (28) 15 (56)
>40% 9 (20) 7 (39) 2 (7)
Percent family income lost due to work disruptions, median (IQR) 21% (5%-37%) 32% (8%-50%) 18% (3%-27%) .10
At least 1 employment disruption in family due to child’s treatmentz 36 (80) 14 (78) 22 (81) 1.00
No change 9 (20) 4 (22) 5 (19) 1.0
Took leave or cut back hours 30 (67) 10 (56) 20 (74) .20
Quit job 6 (13) 3 (17) 3 (11) .70
Laid off from job 2 (4) 0 2 (7) .50
Took on more hours (includes overtime or additional job) 2 (4) 1 (6) 1 (4) 1.00
Perceived ﬁnancial hardship due to transplant
None or a little 16 (36) 6 (33) 10 (37) .20
Moderate 18 (40) 5 (28) 13 (48)
A great deal 11 (24) 7 (39) 4 (15)
Financial stress scoresx
Overwhelming/high stress 15 (33) 8 (44) 7 (26) .20
Average stress 23 (51) 9 (50) 14 (52)
Low stress 7 (16) 1 (6) 6 (22)
Cost-shifting strategiesjj
Reduced or stopped college fund deposits 11 of 34 (32) 4 of 11 (36) 7 of 23 (30) 1.00
Reduced or stopped retirement fund deposits 10 of 37 (27) 2 of 11 (28) 8 of 26 (4) .70
Allowed life insurance policy lapse 3 of 42 (7) 3 of 16 (19) 0 of 26 (0) .049
Data presented are n (%), unless otherwise indicated. P values: Fisher’s exact test was applied for categorical variables and Wilcoxon rank sum test was applied
for continuous variables.
* Survey questions available in Appendix S1.
y Baseline family income was divided by the year-speciﬁc poverty guideline for household size and multiplied by 100 to achieve percentage of FPL.
z Families may have experienced more than one type of disruption due to multiple employed parents, or single parents with multiple disruptions over 6
months.
x Perceived ﬁnancial security was assessed utilizing the standardized InCharge Financial Distress/Financial Well-Being Scale, a 10-item scale with Likert
responses [37].
jj Data pertain to the families with resources of interest (ie, 34 families reported having a college fund).
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receiving cord blood transplants. There were no differences
in child characteristics across income groups, with the
exception that low-income childrenweremore likely to have
Medicaid insurance coverage (44%) than private insurance
coverage (17%) or a combination of Medicaid and private
insurance (39%) (P ¼ .01). One hundred percent of children
were insured before transplantation.Household
A majority of families were 2 parent households (84%),
with a median household size of 4 (IQR, 4 to 5). Congruent
with United States’ data, single parent households were
more likely to be low income (P ¼ .04) [42]. Most families
(60%) reported 2 adults ﬁnancially supporting their child,
with a median family household income before trans-
plantation of $64,920. This was below the 2011 median
family household income among households with children
in Massachusetts ($81,300) and most other New England
states ($61,100 in Rhode Island to $81,500 in Connecticut)
[43]. Using the FPL to standardize household income for
family size and year, 18 (40%) families reported household
incomes before transplantation less than or equal to 200% of
FPL ($44,700 for a family of 4 in 2011) [39]. This is above an
estimated 30% of children living in low-income families in
Massachusetts and other New England States in 2011 (29% in
New Hampshire to 41% in Rhode Island) [44].Parents
Median parental age was 40 years (IQR, 35 to 46), and the
majority of participants were mothers (82%). Parents were
primarily white (91%) and non-Hispanic (87%), and spoke
English as their primary language at home (93%) and these
baseline parental characteristics did not differ across income
categories. Forty-two percent of parents had only a high
school education or less, and low-income parents had less
education (P ¼ .009).Impact of Transplantation on Employment and Finances
As displayed in Table 2, the vast majority of families (80%)
reported at least 1 work disruption due to their child’s
transplantation and this did not differ by income (P ¼ 1.00).
Eight parents (12%) reported either quitting their jobs or
being laid off as a result of their child’s transplantation.
Measures of family ﬁnancial impact because of
transplantation-related work disruptions are presented in
Table 2. As a result of work disruptions, 9 (20%) families
reported losing>40% of their annual income, and low-income
families experienced the greatest impact with 7 (39%)
low-income families reporting such losses compared with 2
(7%)wealthier families (P¼ .02). Despite this disparate impact,
perceived ﬁnancial hardship did not differ across income
groups when measured subjectively (P ¼ .20) or by a stan-
dardized instrument of ﬁnancial stress (P ¼ .20).
Families reported a variety of coping strategies because of
the costs of their child’s illness despite insurance coverage.
Ten (22%) families reported selling personal property, taking
Figure 1. Family material hardship by FPL. This shows the percent of the
cohort reporting each of the measured concrete resource needs, stratiﬁed by
FPL. Comparison of proportions by FPL is denoted with signiﬁcant P values.
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for their child’s medical care. Twelve (26%) families reported
that they had been unable to pay bills because of the cost of
their child’s illness.
Cost-shifting secondary to a child’s transplantation was
common, as depicted in Table 2. Low-income families were
more likely than their richer counterparts to allow a life in-
surance policy to lapse (P ¼ .049).
More than 1 in 3 families (38%) reported either food, en-
ergy, or housing insecurity during the post-transplantation
period, as shown in Figure 1. Low-income families were
more likely to report such concrete resource needs (P ¼ .01).
Exploratory Analysis of the Relationship between Family
Income and Child Patterns of Care and Clinical Outcomes
One child died in the ﬁrst 6 months after transplantation
and no child experienced a disease relapse. Children spent an
average of 49 days in the hospital during their admission for
transplantation and a majority (58%) of children experienced
at least 1 unplanned admission in the ﬁrst 6 months after
transplantation (Table 3). Only 6 (13%) children required
intensive care during their transplantation admission or the
ﬁrst 6 months after. These patterns of care did not differ
across income groups. However, low-income children were
more likely to experience acute or chronic GVHD within 6
months after transplantation than their richer counterparts
(P ¼ .004). Univariate analyses of patterns of care and GVHD
by family report of any material hardship yielded the sameTable 3
Univariate Association between Family FPL and Clinical Outcomes
Clinical Outcomes Total
N ¼ 45
Initial transplantation admission, mean (SD), days 40 (16)
At least 1 unplanned hospital admission after HSCT 26 (58)
Six months post-HSCT admissions, mean (SD), number 2 (1)
ICU stay (admission to 6 mo after) 6 (13)
GVHD 16 (36)
CI indicates conﬁdence interval; ICU, intensive care unit.
Data presented are n (%), unless otherwise indicated. P values: Cochran-Mantel-Ha
was applied for continuous variables.
* Baseline family income was divided by the year-speciﬁc poverty guideline forresults, including a signiﬁcant association between family
material hardship and acute or chronic GVHD (P ¼ .02).DISCUSSION
Utilizing multiple measures of family-reported ﬁnancial
burden, we found that the ﬁnancial impact of pediatric HSCT
on New England families is substantial. Twenty percent of
our cohort reported losing >40% of their annual family in-
come because of HSCT-related work disruptions, and low-
income families were more likely to experience such losses.
A striking 38% of our cohort reported concrete resource
needs during the post-transplantation period, including
food, housing, or energy insecurity. Additionally, in explor-
atory analyses, children from low-income families were
more likely to experience GVHD within 180 of trans-
plantation compared with their wealthier counterparts.
Children from families reporting material hardship were also
more likely to experience GVHD during this time period.
These ﬁndings highlight a rarely discussed component of the
HSCT experience that may have important implications for
patient quality-of-life and clinical outcomes.
The income losses reported by our cohort due to HSCT-
related work disruptions are in concert with prior pediatric
cancer publications [8,9]. They are notably lower than the
50% reported by Khera et al. [28], a discrepancy most likely
due to different measures of income loss [28]. Regardless of
differential measures, our ﬁndings support emerging evi-
dence that HSCT results in signiﬁcant income losses for
families, and that low-income families disproportionately
experience catastrophic income losses. Given no signiﬁcant
differences in rates of work disruptions, we can speculate
that this differential ﬁnancial impact might relate to less
ﬂexible working conditionsdfor example, limited paid leave
opportunities in lower-income families. It is notable that
100% of our cohort was covered by health insurance before
admission for HSCT. As a result, the ﬁnancial burdens re-
ported by these families were above and beyond costs
covered by insurance. The implications of these income
losses and out-of-pocket expenses include cost shifting, such
as decreased or discontinued deposits into retirement or
college funds, as measured in our study, which have unclear
long-term impact on family economic well being. More
proximally, given that income poverty as measured by FPL is
utilized to determine eligibility for many government re-
sources, such decreases in income may increase the pool of
pediatric HSCT families eligible for support, such as food
stamps orMedicaid. Identifying these families in a structured
fashion and helping them to access such programs should be
an important goal for pediatric HSCT centers.Baseline Family Income
as % FPL*
Relative Risk (95% CI) P
200%
n ¼ 18
>200%
n ¼ 27
44 (17) 37 (14) NA .46
12 (67) 14 (52) 1.27 (.80-2.03) .33
2 (1) 2 (1) NA .90
4 (22) 2 (7) 1.92 (.61-6.11) .16
11 (61) 5 (19) 3.30 (1.38, 7.90) .004
enszel test was applied for categorical variables and Wilcoxon rank sum test
household size and multiplied by 100 to achieve percentage of FPL.
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after transplantation at the largest pediatric HSCT center in
New England deserves immediate attention. Although our
data are in line with rates of hardship reported in United
States’ families with children (eg, 20% experienced food
insecurity in 2012 [45]), the presence of such basic needs in
the intensive medical management setting of pediatric HSCT
despite robust psychosocial supports, such as uniform access
to a resource specialist, is concerning. Indeed, our ﬁndings
may well be an underestimate of material hardship for
families served at less well-resourced institutions. Addi-
tionally, material hardship was not exclusively experienced
by low-income families, highlighting the value of multiple
measures of poverty in future research [21,46].
The implications of poverty, and more speciﬁcally mate-
rial hardship, for child HSCT outcomes may be signiﬁcant. In
our exploratory analyses, we identiﬁed a relationship be-
tween GVHD and both family income poverty and family
material hardship in univariate analysis. Needless to say,
such a ﬁnding is preliminary, in that we were unable to
control for known risk factors for GVHD because of an un-
derpowered sample size. It is possible that the relationship
between measures of poverty and GVHD is confounded by
child or donor characteristics or by unmeasured variables,
such as drug compliance. Our ﬁndings suggest an area
worthy of further investigation in a large sample that can
control for known risk factors. It is notable that Baker et al.’s
large database analysis of unrelated donor allogeneic HSCT
recipients found, after adjusting for prognostic variables,
patient income by census zip code to be independently
associated with survival and treatment-related mortality,
albeit not acute or chronic GVHD [32]. Though children were
included in the dataset, they were not analyzed as a separate
subgroup.
How might ﬁnancial hardship translate to poor HSCT-
related outcomes? Data in general pediatrics demonstrate
higher rates of hospitalization and infectious disease for chil-
dren living in homes with material hardship [14,15,20,22,47].
These health care consequences likely extrapolate to the HSCT
setting. Increased exposure to viral or fungal sources of
infection in children living in overcrowded or substandard
housing could plausibly increase the risk for GVHD. Similarly,
prior publications have documented a relationship between
medication adherence and socioeconomic status in children
and adults with chronic disease, which may also increase risk
for GVHD in children [48,49]. Future large cohort studies may
not only conﬁrm our ﬁndings, but may also help identify
mechanistic triggers for GVHD in these homes, such as mold
and viral exposures and adherence behaviors.
Current pediatric HSCT treatment paradigms rely exclu-
sively on biologic factors for risk stratiﬁcation with regard to
GVHD and infectious disease prophylaxis. Our data argue
that pediatric HSCT physicians should consider social de-
terminants as immediately targetable sources of suffering
and potential sources of child morbidity in our population,
pending future investigation. Poverty is an uncomfortable
topic of discussion in the exam room, in large part because
interventions and solutions may seem unclear. Although
HSCTclinicians will not be able to ameliorate income poverty
for their patients, concrete measures of povertydincluding
food, housing, and energy insecuritydare easily evaluable,
and interventions to mitigate concrete resource needs are
feasible. For such interventions to be successfully evaluated,
consensus deﬁnitions on measures of poverty are required,
and uniform prospective collection of such data acrossUnited States centers is warranted. Interventions to reduce
food, housing, or energy insecurity may be as simple as
upfront screening for material hardship with reliance on
institutional social work supports to ameliorate. Alterna-
tively, larger scale policy reforms could be considered,
including automatic eligibility of pediatric HSCT families for
food stamps or other governmental support. Regardless,
deeper understanding of the role of social determinants in
shaping the pediatric HSCT experience will allow for pursuit
of new avenues for supportive care.
Our study is limited by its small sample size and single-
institutional nature. That said, our high response rate (88%)
and excellent completion rate (100% data available for anal-
ysis) suggest our results are representative of children served
by a New England regional referral center. We included only
English-speaking families, and this likely explains the few
minority patients in our cohort.We a priori excluded families
whose child died before our ability to approach for survey,
and this may have biased the patterns of care and clinical
outcomes we identiﬁed. In addition, given the robust psy-
chosocial supports available at our institution, we may have
underestimated the impact of HSCT on family economics and
the prevalence of concrete resource needs. Equally impor-
tant, our study was not powered to detect clinical outcomes
and, thus, we could not further explore the univariate rela-
tionship between income and GVHD controlling for known
risk factors. Similarly, additional relationships between
poverty measures and child HSCT patterns of care may not
have been detected. Finally, given that our data are cross-
sectional in nature, we cannot speak to the trajectory of
economic hardship in HSCT families over time.
CONCLUSION
We found that pediatric HSCT families experience
extraordinary ﬁnancial burden while seeking curative ther-
apy for their children. Whether povertydas measured by
income or concrete resource needsdin fact impacts child
clinical outcomes deserves further investigation. Future
strategies to improve pediatric HSCT outcomes must include
a better understanding of the role of social determinants in
mediating child risk, and the consequences of such curative
therapy for families. In the meantime, the strikingly high
rates of food, housing, and energy insecurity identiﬁed in our
study represent an unacceptable source of burden for pedi-
atric HSCT families. Immediate efforts to design targeted
interventions are warranted.
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